BioCentury | Nov 18, 2002
Finance

Ebb & Flow

...that incorporate in-house or in-licensed delivery technology. Last year, BAX signed a deal to use RTP Pharma's...
BioCentury | Mar 18, 2002
Finance

Ebb & Flow

...LSE:SKP;SKYE) fell 0.5p to 55.5p on news that it had acquired the remaining 59.8% of RTP Pharma...
BioCentury | Mar 18, 2002
Company News

RTP Pharma, SkyePharma deal

...RTP's Insoluble Drug Delivery (IDD) nanoparticle technology is designed to improve the solubility of drugs. RTP Pharma Inc....
BioCentury | Mar 13, 2002
Company News

SkyePharma acquires rest of RTP

...SkyePharma (LSE:SKP; SKYE) acquired the remaining 59.8% of RTP Pharma (Toronto, Ontario) it did not already own...
BioCentury | Sep 24, 2001
Company News

RTP Pharma, Baxter Healthcare Corp. deal

...BAX will use insoluble drug delivery (IDD) technology from RTP Pharma to formulate injectable medications, including water-insoluble...
...exclusive manufacturing rights to resulting compounds, and RTP will receive license fees, milestones and royalties. RTP Pharma Inc....
BioCentury | Sep 18, 2001
Company News

RTP, Baxter drug delivery deal

...BAX will use insoluble drug delivery (IDD) technology from RTP Pharma (Montreal, Quebec) to formulate injectable medications...
BioCentury | Aug 6, 2001
Finance

Ebb & Flow

...84.5p after announcing that it will buy a 40.2% stake in Canadian nanoparticle technology company RTP Pharma...
BioCentury | Aug 6, 2001
Company News

RTP Pharma, SkyePharma deal

RTP Pharma Inc., Toronto, Ontario SkyePharma (LSE:SKP; SKYE), London, U.K. Business: Drug delivery SKP acquired a 40.2% stake in drug delivery company RTP. SKP paid 17.3 million SKP shares valued at $20 million, plus $5...
BioCentury | Aug 1, 2001
Top Story

SKP acquires 40.2% of RTP

...Drug delivery play SkyePharma (LSE:SKP;SKYE) acquired a 40.2% stake in nanoparticle technology company RTP Pharma (Toronto, Ontario...
BioCentury | Feb 5, 2001
Clinical News

Supercritical fluid technology regulatory update

...methods of using supercritical fluid technology to create surface-modified, sub-micron sized particles of water-insoluble drugs. RTP Pharma Inc....
Items per page:
1 - 10 of 22
BioCentury | Nov 18, 2002
Finance

Ebb & Flow

...that incorporate in-house or in-licensed delivery technology. Last year, BAX signed a deal to use RTP Pharma's...
BioCentury | Mar 18, 2002
Finance

Ebb & Flow

...LSE:SKP;SKYE) fell 0.5p to 55.5p on news that it had acquired the remaining 59.8% of RTP Pharma...
BioCentury | Mar 18, 2002
Company News

RTP Pharma, SkyePharma deal

...RTP's Insoluble Drug Delivery (IDD) nanoparticle technology is designed to improve the solubility of drugs. RTP Pharma Inc....
BioCentury | Mar 13, 2002
Company News

SkyePharma acquires rest of RTP

...SkyePharma (LSE:SKP; SKYE) acquired the remaining 59.8% of RTP Pharma (Toronto, Ontario) it did not already own...
BioCentury | Sep 24, 2001
Company News

RTP Pharma, Baxter Healthcare Corp. deal

...BAX will use insoluble drug delivery (IDD) technology from RTP Pharma to formulate injectable medications, including water-insoluble...
...exclusive manufacturing rights to resulting compounds, and RTP will receive license fees, milestones and royalties. RTP Pharma Inc....
BioCentury | Sep 18, 2001
Company News

RTP, Baxter drug delivery deal

...BAX will use insoluble drug delivery (IDD) technology from RTP Pharma (Montreal, Quebec) to formulate injectable medications...
BioCentury | Aug 6, 2001
Finance

Ebb & Flow

...84.5p after announcing that it will buy a 40.2% stake in Canadian nanoparticle technology company RTP Pharma...
BioCentury | Aug 6, 2001
Company News

RTP Pharma, SkyePharma deal

RTP Pharma Inc., Toronto, Ontario SkyePharma (LSE:SKP; SKYE), London, U.K. Business: Drug delivery SKP acquired a 40.2% stake in drug delivery company RTP. SKP paid 17.3 million SKP shares valued at $20 million, plus $5...
BioCentury | Aug 1, 2001
Top Story

SKP acquires 40.2% of RTP

...Drug delivery play SkyePharma (LSE:SKP;SKYE) acquired a 40.2% stake in nanoparticle technology company RTP Pharma (Toronto, Ontario...
BioCentury | Feb 5, 2001
Clinical News

Supercritical fluid technology regulatory update

...methods of using supercritical fluid technology to create surface-modified, sub-micron sized particles of water-insoluble drugs. RTP Pharma Inc....
Items per page:
1 - 10 of 22